Evaluates early immunotherapy outcomes in autoimmune encephalitis, suggesting improved recovery.
To evaluate the clinical characteristics, timing, and outcomes of early immunotherapy in adults with autoimmune-associated seizures, and to compare findings with previously described NORSE and autoimmune encephalitis cohorts.
No takes yet. Share an insight, caveat, or question.
Asaad et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: